» Articles » PMID: 22085500

Vitamin D, Multiple Sclerosis and Inflammatory Bowel Disease

Overview
Publisher Elsevier
Specialties Biochemistry
Biophysics
Date 2011 Nov 17
PMID 22085500
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

It has now been more than 20years since the vitamin D receptor was identified in cells of the immune system. The immune system has now been established as an important target of vitamin D. Vitamin D receptor knockout and vitamin D deficient mice have a surplus of effector T cells that have been implicated in the pathology of multiple sclerosis (MS) and inflammatory bowel disease (IBD). The active form of vitamin D directly and indirectly suppresses the function of these pathogenic T cells while inducing several regulatory T cells that suppress MS and IBD development. There is reason to believe that vitamin D could be an environmental factor that may play a role in the development of these immune mediated diseases in the clinic but at present there has not been a causal relationship established. Nonetheless, current evidence suggests that improving vitamin D status and/or using vitamin D receptor agonists may be useful in MS and IBD.

Citing Articles

Vitamin D deficiency and VDR gene polymorphism FokI (rs2228570) are associated with diabetes mellitus in adults: COVID-inconfidentes study.

de Moura S, de Menezes-Junior L, Rocha A, Batista A, Sabiao T, de Menezes M Diabetol Metab Syndr. 2024; 16(1):118.

PMID: 38812030 PMC: 11137993. DOI: 10.1186/s13098-024-01328-6.


The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses.

Shor S, Schweig S Microorganisms. 2023; 11(7).

PMID: 37512931 PMC: 10384908. DOI: 10.3390/microorganisms11071759.


Vitamin D and Autoimmune Rheumatic Diseases.

Athanassiou L, Kostoglou-Athanassiou I, Koutsilieris M, Shoenfeld Y Biomolecules. 2023; 13(4).

PMID: 37189455 PMC: 10135889. DOI: 10.3390/biom13040709.


Vitamin D in pediatric age: Current evidence, recommendations, and misunderstandings.

Corsello A, Spolidoro G, Milani G, Agostoni C Front Med (Lausanne). 2023; 10:1107855.

PMID: 37007781 PMC: 10060648. DOI: 10.3389/fmed.2023.1107855.


Inflammatory Bowel Disease and Neurodegenerative Diseases.

Kim J, Chen M, Wang H, Lu C, Wang Y, Zhang B Gut Liver. 2023; 17(4):495-504.

PMID: 36843420 PMC: 10352055. DOI: 10.5009/gnl220523.


References
1.
Pachner A . Experimental models of multiple sclerosis. Curr Opin Neurol. 2011; 24(3):291-9. DOI: 10.1097/WCO.0b013e328346c226. View

2.
Iwakura Y, Ishigame H . The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116(5):1218-22. PMC: 1451213. DOI: 10.1172/JCI28508. View

3.
Barrat F, Cua D, Boonstra A, Richards D, Crain C, Savelkoul H . In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002; 195(5):603-16. PMC: 2193760. DOI: 10.1084/jem.20011629. View

4.
Tang J, Zhou R, Luger D, Zhu W, Silver P, Grajewski R . Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol. 2009; 182(8):4624-32. PMC: 2756755. DOI: 10.4049/jimmunol.0801543. View

5.
Madsen K, Doyle J, Tavernini M, Jewell L, Rennie R, Fedorak R . Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000; 118(6):1094-105. DOI: 10.1016/s0016-5085(00)70362-3. View